Richard Allen White JR - 01 Jan 2022 Form 3 Insider Report for Ingevity Corp (NGVT)

Role
SVP, Perf Chem and Pres, ISPT
Signature
/s/ Richard Allen White, Jr. By: Ryan C. Fisher as Attorney-in-Fact
Issuer symbol
NGVT
Transactions as of
01 Jan 2022
Net transactions value
$0
Form type
3
Filing time
10 Jan 2022, 13:44:47 UTC
Next filing
01 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding NGVT Common Stock 3,145 01 Jan 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NGVT Employee Stock Option (right to buy) 01 Jan 2022 Common Stock 2,458 $45.04 Direct F1
holding NGVT Employee Stock Option (right to buy) 01 Jan 2022 Common Stock 1,366 $69.48 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options are granted pursuant to the Ingevity Corporation 2016 Omnibus Incentive Plan. Such options vest ratably in three tranches. The first tranche vested February 28, 2021 and the remaining tranches will vest on February 28, 2022 and February 28, 2023.
F2 These options are granted pursuant to the Ingevity Corporation 2016 Omnibus Incentive Plan. Such options will vest ratably beginning February 26, 2022, 2023, and 2024.

Remarks:

Exhibits: Exhibit 24 - Power of Attorney